Beryl Drugs Limited (BOM:524606)
India
· Delayed Price · Currency is INR 20.35
+1.73 (9.29%)
At close: Mar 10, 2026
Beryl Drugs Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2020 - 2016 |
| Net Income | - | 5.79 | 7.69 | 7.66 | -6.59 | 2.4 | Upgrade
|
| Depreciation & Amortization | - | 12.46 | 12 | 8.14 | 10.87 | 12.74 | Upgrade
|
| Other Amortization | - | 0 | 0 | - | - | - | Upgrade
|
| Loss (Gain) From Sale of Assets | - | - | -0.11 | - | - | - | Upgrade
|
| Loss (Gain) From Sale of Investments | - | - | - | - | - | -4.52 | Upgrade
|
| Other Operating Activities | - | 5.03 | 3.77 | 4.65 | -0.43 | 4.09 | Upgrade
|
| Change in Accounts Receivable | - | 21.27 | -6.84 | -24.52 | 0.92 | -10.87 | Upgrade
|
| Change in Inventory | - | -6.43 | -2.06 | 19.24 | -7.09 | -11.12 | Upgrade
|
| Change in Accounts Payable | - | -9.01 | -12.32 | 1.91 | -0.47 | 4.18 | Upgrade
|
| Change in Other Net Operating Assets | - | -2.75 | 6.06 | 6.83 | -1.89 | 6.48 | Upgrade
|
| Operating Cash Flow | - | 26.37 | 8.2 | 23.91 | -4.69 | 3.39 | Upgrade
|
| Operating Cash Flow Growth | - | 221.46% | -65.70% | - | - | 83.18% | Upgrade
|
| Capital Expenditures | - | -21.85 | -13.52 | -15.64 | -4.16 | -16.72 | Upgrade
|
| Sale of Property, Plant & Equipment | - | - | 0.21 | - | - | - | Upgrade
|
| Investment in Securities | - | - | 2.19 | - | - | 9.72 | Upgrade
|
| Other Investing Activities | - | 17.88 | 0.3 | 3.86 | 9.4 | 9.55 | Upgrade
|
| Investing Cash Flow | - | -3.97 | -10.82 | -11.77 | 5.24 | 2.55 | Upgrade
|
| Short-Term Debt Issued | - | - | 7.97 | - | 4.81 | - | Upgrade
|
| Long-Term Debt Issued | - | 12.48 | - | 11.52 | 16.75 | 7.6 | Upgrade
|
| Total Debt Issued | - | 12.48 | 7.97 | 11.52 | 21.56 | 7.6 | Upgrade
|
| Short-Term Debt Repaid | - | -3.62 | - | -17.84 | - | - | Upgrade
|
| Long-Term Debt Repaid | - | -19.07 | -2.45 | -1.2 | -19.86 | -8.32 | Upgrade
|
| Total Debt Repaid | - | -22.69 | -2.45 | -19.04 | -19.86 | -8.32 | Upgrade
|
| Net Debt Issued (Repaid) | - | -10.21 | 5.52 | -7.52 | 1.7 | -0.72 | Upgrade
|
| Other Financing Activities | - | -5.3 | -4.49 | -4.51 | -4.06 | -4.66 | Upgrade
|
| Financing Cash Flow | - | -15.5 | 1.03 | -12.02 | -2.36 | -5.38 | Upgrade
|
| Miscellaneous Cash Flow Adjustments | - | - | 0 | 0 | - | - | Upgrade
|
| Net Cash Flow | - | 6.89 | -1.58 | 0.12 | -1.81 | 0.56 | Upgrade
|
| Free Cash Flow | - | 4.52 | -5.31 | 8.28 | -8.84 | -13.33 | Upgrade
|
| Free Cash Flow Margin | - | 2.14% | -1.99% | 3.08% | -6.05% | -9.46% | Upgrade
|
| Free Cash Flow Per Share | - | 0.89 | -1.05 | 1.63 | -1.74 | -2.63 | Upgrade
|
| Cash Interest Paid | - | 5.18 | 4.45 | 4.16 | 3.97 | 4.66 | Upgrade
|
| Cash Income Tax Paid | - | 1.8 | 2 | 0.61 | 0.31 | 0.22 | Upgrade
|
| Levered Free Cash Flow | - | 2.36 | -11.53 | -4.51 | -4.9 | -16.47 | Upgrade
|
| Unlevered Free Cash Flow | - | 5.61 | -8.73 | -1.9 | -2.28 | -13.8 | Upgrade
|
| Change in Working Capital | - | 3.09 | -15.15 | 3.46 | -8.53 | -11.32 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.